Digital Ally, Inc. (Nasdaq: DGLY) Wins Appellate Verdict – Shares Rocket

Digital Ally, Inc. – Nasdaq: DGLY

Traders continue to push Kansas-based Digital Ally Inc. shares higher, on large volumes, after a favorable appeals court ruling found against Utility Associates, Inc. The shares, traded on the Nasdaq under ticker DGLY, began the week at $4.15 and reached $5.20 in after-hours trading on Thursday. 

Digital Ally™, Inc. develops, manufactures and markets advanced technology products for law enforcement, homeland security and commercial fleet applications – focusing in Digital Video Imaging and Storage. Digital Ally has secured contracts and orders from law enforcement agencies, the U.S. Military and commercial fleets in all 50 states and more than 90 foreign countries.  

Stanton E. Ross, Chief Executive Officer of Digital Ally responded to news of the appeal court’s decision “This Judgment by the Federal Circuit is a huge legal victory for Digital and affirms what we have known all along — Utility has been threatening Digital and our customers with an invalid patent.” 

Two firms follow Digital Ally, Inc. and both rate DGLY shares as a “Strong Buy” with a consensus price target of $12. DGLY shares have never had positive EPS – 2011 (-$1.96), 2012 (-0.97), 2013 (-$1.17), 2014 (-$3.54), and in 2015 (-$2.77). Digital Ally reported sales in 2015 were $20 million – little changed from previous years. 

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/19/2017
Ticker Symbol DGLY
Last Price a/o 4:44 PM EST  $                      5.20
Average Volume 57,600
Market Cap $25.33 million
Sales $18.2 million
Shares Outstanding 5.39 million
Share Float 4.67 million
Shortable Yes
Optionable No
Inside Ownership 1.70%
Short Float 13.43%
Short Interest Ratio 10.89
Quarterly Return -17.54%
YTD Return 11.90%
Year Return -25.04%

South Korean Gravity Co. Ltd. (Nasdaq: GRVY) Shares on the Rise

Gravity Co. Ltd. – Nasdaq: GRVY

South Korean-based Gravity Co. Ltd shares are up over 30% today and up over 150% for the quarter. The shares, traded on the Nasdaq under ticker GRVY, had traded under $5 for most of 2016 but hit an intra-day high of $19.51 in today’s trading.

Gravity Co. Ltd. is widely known for its development of the internationally acclaimed

Ragnarok Online, and is also developing and servicing a full lineup of next-generation game titles including the sequel Ragnarok Online II, Requiem. Also, Gravity Co. Ltd is developing its publishing business by providing a wide variety of renowned game titles to our users based on the company’s global network. 

GRVY shares have not been helped by declining sales. In 2011 and 2012 reported sales were close to $49 million. However, in 2015 sales were just $30.3 million. 2015 EPS for GRVY were the best in the past three years although still a loss – $4.15. No firms follow or rate GRVY shares.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

Ticker Symbol GRVY
Last Price a/o 3:12 PM EST  $                    17.93
Average Volume 150,000
Market Cap $45.8 million
Sales $36.3 million
Shares Outstanding 3.37 million
Share Float 1.41 million
Shortable Yes
Optionable No
Inside Ownership 59.30%
Short Float 1.76%
Short Interest Ratio 0.17
Quarterly Return 166.47%
YTD Return 28.82%
Year Return 325.46%

IRadimed Corporation (Nasdaq: IRMD) Gives 2017 Guidance – Shares Drop

IRadimed Corporation – Nasdaq: IRMD

IRadimed Corporation shares dropped on heavy volume after the medical appliance manufacturer released financial guidance for 2017. Yesterday shares, traded on the Nasdaq under ticker IRMD, ended the regular session at $12.15 but dropped to a low of $8.86 in early morning trading.

For the first quarter 2017, the Company expects to report revenue of $5.2 million to $5.3 million, GAAP diluted earnings per share of $(0.01) to $(0.02) and non-GAAP diluted earnings per IRMD share of $0.00 to $0.01. The Company also announced that it expects to report revenue of approximately $32.6 million for the full year 2016 and $6.1 million for the fourth quarter 2016.

IRadimed Corporation develops and manufactures the MRI IV Infusion System. The company pioneered the development of the world’s first and best-selling MRI Patient Monitoring System. IRadimed has a combined 60+ years developing innovative MRI patient care products.

Two firms follow IRadimed Corporation. Their analysts rate IRMD as a “Hold” with a consensus price target of $11.50. EPS for IRMD has been positive and increasing from 2012 ($0.10) to 2015 ($0.68). IRadimed Corporation also has increasing reported sales from 2012 ($7.7 million) to 2015 ($31.6 million).

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/18/2017
Ticker Symbol IRMD
Last Price a/o 10:24 PM EST  $                    10.21
Average Volume 67,700
Market Cap $129.64 million
Sales $35.3 million
Shares Outstanding 10.67 million
Share Float 4.48 million
Shortable Yes
Optionable No
Inside Ownership 1.60%
Short Float 23.92%
Short Interest Ratio 11.5
Quarterly Return 28.71%
YTD Return 9.46%
Year Return -41.42%

Shiloh Industries Inc. (Nasdaq: SHLO) Gains in After-Hours on Earnings

Shiloh Industries, Inc. – Nasdaq: SHLO

Shares of Valley City, OH-based Shiloh Industries, Inc. are up over 10% in after-hours trading on a positive earnings announcement. Shiloh Industries trades on the Nasdaq under ticker symbol SHLO. After the market closed, Shiloh reported net income of $5.3 million for the quarter in comparison to a loss for the same quarter last year.

Shiloh Industries, Inc. is a global supplier of lightweighting, noise and vibration solutions to the automotive, commercial vehicle and industrial segments, capable of delivering solutions in aluminum, magnesium, steel and high-strength steel alloys to original equipment manufacturers and suppliers.

In the last year SHLO shares have appreciated almost 90%. In 2011 they reported earnings of $0.47 on sales of $520 million. In 2015 Shiloh Industries reported $0.48 EPS on sales of $1.11 Billion. SHLO is not followed by any analysts.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/17/2017
Ticker Symbol SHLO
Last Price a/o 4:59 PM EST  $                      8.65
Average Volume 27,000
Market Cap $129.4 million
Sales $1.08 Billion
Shares Outstanding 16.61 million
Share Float 8.35 million
Shortable Yes
Optionable Yes
Inside Ownership 1.90%
Short Float 0.29%
Short Interest Ratio 0.88
Quarterly Return 11.60%
YTD Return 12.74%
Year Return 90.00%

Progress Software Corporation (Nasdaq: PRGS) Tumbles After Disappointing Earnings, Revenues

Progress Software Corporation – Nasdaq: PRGS

The market expressed its disappointment in the reported earnings and revenue announcement of Progress Software Corporation by selling shares of PRGS and sending the stock gapping down on the open. PRGS ended Friday at $32.25 but opened Tuesday at $29.46. PRGS continued to come under pressure through the trading day and ended at $27.63.

Progress Software Corporation provides business software solutions for various industries worldwide. Chief Executive Officer Yogesh Gupta said in a release “I am pleased with our earnings per share and adjusted free cash flow performance during the quarter despite revenue falling short of our goals. Initiatives undertaken during the quarter to manage our expenses allowed us to reach this outcome. I am excited by the opportunities we have in front of us, and look forward to what we can accomplish in 2017 and beyond.”

Analysts had expected EPSof $0.62 but Progress Software reported $0.56. Similarly, expectations of $124 million in revenues were met with a figure of $118. Three firms cover PRGS with one rating it a “Strong Buy” and the other two rate PRGS as a “Hold”.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/17/2017
Ticker Symbol PRGS
Last Price a/o 3:53 PM EST  $                    27.62
Average Volume 200,000
Market Cap $1.54 Billion
Sales $40.3 million
Shares Outstanding 47.7 million
Share Float 47.34 million
Shortable Yes
Optionable Yes
Inside Ownership 1.50%
Short Float 1.54%
Short Interest Ratio 3.66
Quarterly Return 19.86%
YTD Return 1.00%
Year Return 29.49%

 

The Advisory Board Company (Nasdaq: ABCO) Boosted by Elliott Hedge Fund Stake

The Advisory Board Company – Nasdaq: ABCO

Renowned hedge fund Elliott Management Corporation has today disclosed an 8.3% stake in The Advisory Board Company and described its shares (Nasdaq: ABCO) as “undervalued”. In response, the shares (Nasdaq: ABCO) gapped up from their Wednesday close of $36.15 and have climbed over 15% in today’s trading.

The Advisory Board Company’s offers cloud-based business intelligence and software applications that allow members to combine insights derived from best practices research with their operational and financial data to identify and assess revenue, cost-saving, or performance improvement opportunities; and consulting and management services that provide on-the-ground support for turnaround and performance improvement initiatives, as well as best practice and day-in-day-out professional management of the hospital or medical group areas.

Elliott Management Corporation is noted for its relatively high returns and low volatility. The New York Times has called its founder, Paul Singer, “one of the most revered” hedge fund managers on Wall Street. Elliott returns have generally outpaced the annual growth of the S&P 500. Describing Singer in 2012 as “one of the smartest and toughest money managers in the business,” Fortune noted that over the previous 35 years, he had “produced an extraordinary 14% average annual return after fees, nearly double the price appreciation of the S&P 500.” From inception, Elliott has generated for its investors a 14.6% net compound annual return, compared to 10.9% for the S&P 500 stock index, while having only one-third of the index’s volatility. The firm is currently closed to new investors. As of mid-2008, Elliott counted 175 employees in New York City, London, Tokyo, and Hong Kong and is one of the oldest hedge funds under continuous management.

Last year The Advisory Board Company posted it largest EPS loss of the last four years (-$2.84) at the same time it posted its largest sales figures ($768 million). Seventeen firms follow The Advisory Board Company and nine give ABCO a rating of “Strong Buy”, seven give it a “Hold” rating, and one gives ABCO a “Underperform” rating.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/12/2017
Ticker Symbol ABCO
Last Price a/o 1:23 PM EST  $                    41.63
Average Volume 501,000
Market Cap $1.45 Billion
Sales $803 million
Shares Outstanding 40.1 million
Share Float 6.76
Shortable Yes
Optionable Yes
Inside Ownership 0.30%
Short Float 6.76%
Short Interest Ratio 5.35
Quarterly Return -15.97%
YTD Return 8.72%
Year Return -22.34%

Century Aluminum (Nasdaq: CENX) Up on WTO Complaint Reports

Century Aluminum Company – Nasdaq: CENX

Reports that the U.S. may launch formal complaints with the World Trade Organization against Chinese aluminum producers sent shares of Century Aluminum (Nasdaq: CENX) up at least 10% in early trading. The U.S. intends, according to reports, to accuse China of providing below-market financing to Chinese aluminum companies that allowed them to modernize their plants and expand production. Also, allegedly in the complaint, are accusations that the Chinese aluminum producers were sold energy, in the form of coal and electricity, at below-market rates.

Chicago, IL-based Century Aluminum Company is a global producer of aluminum and operates aluminum reduction facilities in the United States and Iceland. Century Aluminum owns three U.S. aluminum smelters, in Hawesville, Kentucky, Robards, Kentucky and Mt. Holly, South Carolina, and one smelter in Grundartangi, Iceland. In 2008, Century Aluminum began construction on an aluminum reduction facility in Helguvik, Iceland, construction of which is currently delayed.

Four firms follow Century Aluminum Company and all rate shares of CENX as a “Hold”. CENX is currently trading above its consensus price target of $7.50.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/12/2017
Ticker Symbol CENX
Last Price a/o 10:13 AM EST  $                    10.01
Average Volume 2 million
Market Cap $809 million
Sales $1.36 Billion
Shares Outstanding 90 million
Share Float 49.3 million
Shortable Yes
Optionable Yes
Inside Ownership 43.00%
Short Float 23.31%
Short Interest Ratio 5.63
Quarterly Return 20.51%
YTD Return 5.02%
Year Return 201.68%

Kornit Digital Ltd. (Nasdaq: KRNT) Up on Amazon Deal

Kornit Digital Ltd. – Nasdaq: KRNT

A deal with Amazon (Nasdaq: AMZN) has sent shares of Israel-based Kornit Digital Ltd. shares up over 20%. Kornit Digital Ltd. trades under ticker KRNT on the Nasdaq. Kornit Digital develops, manufactures and markets industrial and commercial printing solutions for the garment, apparel and textile industries. Through the Amazon agreement, Kornit will support Amazon’s production capacity for printed textiles.

Gabi Seligsohn, CEO of Kornit explained the deal “We are excited to have been selected as a garment printing solution provider for Amazon, and look forward to the business potential this relationship represents… Kornit Digital is at the forefront of the digital direct-to-garment market, and we believe that Amazon’s decision is great testament to that. We are deeply committed to the success of our business with Amazon and reiterate our commitment to all of our customers to stay at the forefront of the DTG market and continue to provide them with the most advanced, cost effective production solutions.”

Kornit Digital has had increasing EPS over the last three years – from $0.04 to $0.19. The company has also reported increasing sales over the past four years – from $39.2 million to $86.4 million. All three firms that cover KRNT rate it as a “Strong Buy”.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/11/2017
Ticker Symbol KRNT
Last Price a/o 11:30 AM EST  $                    16.10
Average Volume 73,000
Market Cap $420 million
Sales $102 million
Shares Outstanding 30.13 million
Share Float 29.44 million
Shortable Yes
Optionable No
Inside Ownership
Short Float 3.40%
Short Interest Ratio 13.74
Quarterly Return 38.39%
YTD Return 10.28%
Year Return 33.37%

Allscripts Healthcare Solutions Inc. (Nasdaq: MDRX) Posts Financial Results – Shares Rise

Allscripts Healthcare Solutions, Inc. – Nasdaq: MDRX

Allscripts Healthcare Solutions, Inc., traded on the Nasdaq under ticker symbol MDRX, announced preliminary financial results for the fourth quarter ended Dec. 31, 2016. The company anticipates consolidated bookings for the 4th quarter of 2016 to exceed $400 million, a fourth-quarter record. This result implies annual bookings growth of over 17 percent. Shares of MDRX hav responded by increasing almost 10% in early trading.

Paul M. Black, Allscripts’ Chief Executive Officer stated in a press release “Our investments in our solutions continue to increase our competitiveness, reflected in signed agreements which added the largest number of new Sunrise facilities in our history. Our initial outlook for 2017 illustrates confidence this growth momentum will continue this year across Allscripts comprehensive offerings to payers and providers globally.”

Chicago, IL-based Allscripts Healthcare Solutions Inc. is a leader in healthcare information technology solutions that advance clinical, financial, and operational results. Twenty-one firms follow Allscripts Healthcare and twelve rate MDRX as a “Hold”, one rates it as a “Buy” and eight rate MDRX as a “Strong Buy”.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

 

Exelixis Inc. (Nasdaq: EXEL) Shares Higher on Resolution of Dispute with Genentech

Exelixis, Inc. – Nasdaq: EXEL

Genentech’s announcement to stop charging Exelixis, Inc. some expenses under their collaboration agreement sent EXEL shares almost 15% higher today. Exelixis Inc. is a San Fransico, CA-based biopharmaceutical company that develops molecular therapies with the potential to improve the treatment of cancer.

Exelixis and Genentech have shared promotional costs since commercial activities were initiated in early 2013. As detailed in previous regulatory filings, Exelixis charged its Profit and Loss Statement approximately $38 million for promotional costs through the third quarter of 2016. With the new approach that Genentech has adopted unilaterally, Exelixis’ liability for promotional costs will be reduced to approximately $15 million for the same period. Exelixis Inc. will not have to pay$18.7 million in disputed costs, and Exelixis will receive $7.1 million for expenses they had already paid – plus interest.

Six firms follow Exwlixis, INC. All six rate shares of EXEL as a “String Buy” The consensus price target is $21.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

1/9/2017
Ticker Symbol EXEL
Last Price a/o 4:00 PM EST  $                    17.58
Average Volume 5.98 million
Market Cap $4.93 Billion
Sales $123.8 million
Shares Outstanding 280.3 million
Share Float 260.59 million
Shortable Yes
Optionable Yes
Inside Ownership 0.80%
Short Float 6.52%
Short Interest Ratio 2.84
Quarterly Return 35.75%
YTD Return 17.91%
Year Return 259.51%